ZBH Zimmer Biomet Holdings Inc

Price (delayed)

$178.45

Market cap

$37.09B

P/E Ratio

N/A

Dividend/share

$0.96

EPS

-$0.67

Enterprise value

$44.42B

Sector: Healthcare
Industry: Medical Devices

Zimmer Biomet is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of ...

Highlights

ZBH's equity is up by 2.7% since the previous quarter
The EPS has plunged by 112% YoY but it has grown by 8% from the previous quarter
The net income has dropped by 112% year-on-year but it has grown by 9% since the previous quarter
Zimmer Biomet Holdings's gross profit has decreased by 15% YoY and by 2.1% from the previous quarter
The revenue has contracted by 12% YoY

Key stats

What are the main financial stats of ZBH
Market
Shares outstanding
207.86M
Market cap
$37.09B
Enterprise value
$44.42B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.03
Price to sales (P/S)
5.26
EV/EBIT
N/A
EV/EBITDA
45.85
EV/Sales
6.32
Earnings
Revenue
$7.02B
EBIT
-$63.9M
EBITDA
$968.8M
Free cash flow
$794.9M
Per share
EPS
-$0.67
Free cash flow per share
$3.84
Book value per share
$58.83
Revenue per share
$33.93
TBVPS
$39.13
Balance sheet
Total assets
$24.42B
Total liabilities
$12.22B
Debt
$8.13B
Equity
$12.19B
Working capital
$2.53B
Liquidity
Debt to equity
0.67
Current ratio
1.99
Quick ratio
0.88
Net debt/EBITDA
7.56
Margins
EBITDA margin
13.8%
Gross margin
69.7%
Net margin
-2%
Operating margin
-1.2%
Efficiency
Return on assets
-0.6%
Return on equity
-1.2%
Return on invested capital
-0.5%
Return on capital employed
-0.3%
Return on sales
-0.9%
Dividend
Dividend yield
0.54%
DPS
$0.96
Payout ratio
N/A

ZBH stock price

How has the Zimmer Biomet Holdings stock price performed over time
Intraday
0.6%
1 week
3.82%
1 month
14.29%
1 year
57.93%
YTD
15.81%
QTD
11.48%

Financial performance

How have Zimmer Biomet Holdings's revenue and profit performed over time
Revenue
$7.02B
Gross profit
$4.9B
Operating income
-$87.8M
Net income
-$138.9M
Gross margin
69.7%
Net margin
-2%
The net margin has dropped by 114% year-on-year but it has increased by 9% since the previous quarter
The net income has dropped by 112% year-on-year but it has grown by 9% since the previous quarter
Zimmer Biomet Holdings's operating income has shrunk by 108% YoY
Zimmer Biomet Holdings's operating margin has shrunk by 108% YoY

Growth

What is Zimmer Biomet Holdings's growth rate over time

Valuation

What is Zimmer Biomet Holdings stock price valuation
P/E
N/A
P/B
3.03
P/S
5.26
EV/EBIT
N/A
EV/EBITDA
45.85
EV/Sales
6.32
The EPS has plunged by 112% YoY but it has grown by 8% from the previous quarter
The stock's P/B is 37% above its 5-year quarterly average of 2.2 and 37% above its last 4 quarters average of 2.2
ZBH's equity is up by 2.7% since the previous quarter
ZBH's price to sales (P/S) is 58% higher than its 5-year quarterly average of 3.3 and 41% higher than its last 4 quarters average of 3.7
The revenue has contracted by 12% YoY

Efficiency

How efficient is Zimmer Biomet Holdings business performance
Zimmer Biomet Holdings's return on equity has shrunk by 113% YoY but it has increased by 8% QoQ
The ROA has plunged by 113% YoY
The ROS has plunged by 106% YoY
The ROIC has shrunk by 105% YoY

Dividends

What is ZBH's dividend history
DPS
$0.96
Dividend yield
0.54%
Payout ratio
N/A
Recent dividends

Financial health

How did Zimmer Biomet Holdings financials performed over time
The total assets is 100% higher than the total liabilities
ZBH's quick ratio has soared by 52% YoY but it is down by 14% QoQ
The current ratio has grown by 45% YoY but it has contracted by 12% from the previous quarter
The debt is 33% smaller than the equity
The debt to equity has declined by 4.3% since the previous quarter
ZBH's equity is up by 2.7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.